MicroRNA-142-3p regulates TGF-β3-mediated region-dependent chondrogenesis by regulating ADAM9

Biochemical and Biophysical Research Communications

Volumn 414, Issue 4, 2011, Pages 653-659

  Kim, Dongkyun ^a   Song, Jinsoo ^a   Kim, Sunhyo ^a   Kang, Shin Sung ^b,c   Jin, Eun Jung ^a  

^a Wonkwang University   (South Korea)

^b University of Ulsan   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

ADAM9; Chondrogenesis; Limb type specific; MiR 142 3p

Indexed keywords

ADAM PROTEIN; ANTISENSE OLIGONUCLEOTIDE; MICRORNA; MICRORNA 142 3P; PROTEIN ADAM9; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CHONDROGENESIS; CONTROLLED STUDY; DOWN REGULATION; LIMB BUD; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ADAM PROTEINS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHICK EMBRYO; CHONDROGENESIS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; LOWER EXTREMITY; MESODERM; MICRORNAS; TRANSFORMING GROWTH FACTOR BETA3; WING;

EID: 80555122824     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.104     Document Type: Article

References (46)

1. Bell E., Saunders J.W., Zwilling E. Limb development in the absence of ectodermal ridge. Nature 1959, 184:1736-1737.
2. Zwilling R. On the evolution of endopeptidases. VI. Specific inhibition by hirudin of proteases from vertebrates and invertebrates. Hoppe. Seylers. Z. Physiol. Chem. 1968, 349:1787-1788.
3. Sun W., Shen W., Yang S., Hu F., Li H., Zhu T.H. MiR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β. Cell Res. 2010, 20:1158-1169.
4. Downie S.A., Newman S.A. Morphogenetic differences between fore and hind limb precartilage mesenchyme: relation to mechanisms of skeletal pattern formation. Dev. Biol. 1994, 162:195-208.
5. Newman S.A., Müller G.B. Origination and innovation in the vertebrate limb skeleton: an epigenetic perspective. J. Exp. Zool. B. Mol. Dev. Evol. 2005, 304:593-609.
6. Chimal-Monroy J., Díaz de León L. Expression of N-cadherin, N-CAM, fibronectin and tenascin is stimulated by TGF-beta1, beta2, beta3 and beta5 during the formation of precartilage condensations. Int J Dev Biol. 1999, 43:59-67.
7. Downie S.A., Newman S.A. Different roles for fibronectin in the generation of fore and hind limb precartilage condensations. Dev. Biol. 1995, 172:519-530.
8. DeLise A.M., Fischer L., Tuan R.S. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 2000, 8:309-334.
9. Johnson R.L., Tabin C.J. Molecular models for vertebrate limb development. Cell 1997, 90:979-990.
10. Knudson C.B., Knudson W. Cartilage proteoglycans. Semin. Cell Dev. Biol. 2001, 12:69-78.
11. Knudson C.B., Nofal G.A., Pamintuan L., Aguiar D.J. The chondrocyte pericellular matrix: a model for hyaluronan-mediated cell-matrix interactions. Biochem. Soc. Trans. 1999, 27:142-147.
12. Sandell L.J., Adler P. Developmental patterns of cartilage. Front. Biosci. 1999, 4:731-742.
13. Bang O.S., Kim E.J., Chung J.G., Lee S.R., Park T.K., Kang S.S. Association of focal adhesion kinase with fibronectin and paxillin is required for precartilage condensation of chick mesenchymal cells. Biochem. Biophys. Res. Commun. 2000, 278:522-529.
14. Primakoff P., Myles D.G. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 2000, 16:83-87.
15. Yamamoto S., Higuchi Y., Yoshiyama K., Shimizu E., Kataoka M., Hijiya N., Matsuura K. ADAM family proteins in the immune system. Immunol. Today 1999, 20:278-284.
16. Kuno K., Kanada N., Nakashima E., Fujiki F., Ichimura F., Matsushima K. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J. Biol. Chem. 1997, 272:556-562.
17. Hartmann D., de Strooper B., Serneels L., Craessaerts K., Herreman A., Annaert W., Umans L., Lübke T., Lena Illert A., von Figura K., Saftig P. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum. Mol. Genet. 2002, 11:2615-2624.
18. Fambrough D., Pan D., Rubin G.M., Goodman C.S. The cell surface metalloprotease/disintegrin Kuzbanian is required for axonal extension in Drosophila. Proc. Natl. Acad. Sci. USA 1996, 93:13233-13238.
19. Schimmelpfeng K., Gögel S., Klämbt C. The function of leak and kuzbanian during growth cone and cell migration. Mech. Dev. 2001, 106:25-36.
20. Millichip M.I., Dallas D.J., Wu E., Dale S., McKie N. The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem. Biophys. Res. Commun. 1998, 245:594-598.
21. Martin J., Eynstone L.V., Davies M., Williams J.D., Steadman R. The role of ADAM 15 in glomerular mesangial cell migration. J. Biol. Chem. 2002, 277:33683-33689.
22. Alfandari D., Cousin H., Gaultier A., Smith K., White J.M., Darribère T., DeSimone D.W. Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration. Curr. Biol. 2001, 11:918-930.
23. Luo Y., High F.A., Epstein J.A., Radice G.L. N-cadherin is required for neural crest remodeling of the cardiac outflow tract. Dev Biol. 2006, 299:517-528.
24. Kim B.M., Woo J., Kanellopoulou C., Shivdasani R.A. Regulation of mouse stomach development and Barx1 expression by specific microRNAs. Development 2011, 138:1081-1086.
25. Zovoilis A., Smorag L., Pantazi A., Engel W. Members of the miR-290 cluster modulate in vitro differentiation of mouse embryonic stem cells. Differentiation 2009, 78:69-78.
26. Hall B.K., Miyake T. All for one and one for all: condensations and the initiation of skeletal development. Bioessays 2000, 22:138-147.
27. Kosher R.A., Walker K.H. The effect of prostaglandins on in vitro limb cartilage differentiation. Exp. Cell Res. 1983, 145:145-153.
28. Swalla B.J., Owens E.M., Linsenmayer T.F., Solursh M. Two distinct classes of prechondrogenic cell types in the embryonic limb bud. Dev. Biol. 1983, 97:59-69.
29. Nelson C.M., Tien J. Microstructured extracellular matrices in tissue engineering and development. Curr. Opin. Biotechnol. 2006, 17:518-523.
30. Karousou E., Ronga M., Vigetti D., Passi A., Maffulli N. Collagens, proteoglycans, MMP-2, MMP-9 and TIMPs in human achilles tendon rupture. Clin Orthop Relat Res. 2008, 466:1577-1582.
31. Dai R., Ahmed S.A. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl. Res. 2011, 157:163-179.
32. Wittmann J., Jäck H.M. MicroRNAs in rheumatoid arthritis: midget RNAs with a giant impact. Ann. Rheum. Dis. 2011, 1:92-96.
33. Silvestri P., Di Russo C., Rigattieri S., Fedele S., Todaro D., Ferraiuolo G., Altamura G., Loschiavo P. MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets. Recent Pat. Cardiovasc. Drug Discov. 2009, 4:109-118.
34. Kowarsch A., Marr C., Schmidl D., Ruepp A., Theis F.J. Tissue-specific target analysis of disease-associated microRNAs in human signaling pathways. PLoS One 2010, 5:e11154.
35. Wu L., Cai C., Wang X., Liu M., Li X., Tang H. MicroRNA-142-3p, a new regulator of RAC1. Suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett. 2011, 585:1322-13230.
36. Waters S.I., White J.M. Biochemical and molecular characterization of bovine fertilin alpha and beta (ADAM 1 and ADAM 2): a candidate sperm-egg binding/fusion complex. Biol. Reprod. 1997, 56:1245-1254.
37. Moghadaszadeh B., Albrechtsen R., Guo L.T., Zaik M., Kawaguchi N., Borup R.H., Kronqvist P., Schroder H.D., Davies K.E., Voit T., Nielsen F.C., Engvall E., Wewer U.M. Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin. Utrophin and associated glycoproteins. Hum. Mol. Genet. 2003, 12:2467-2479.
38. Ebi M., Kataoka H., Shimura T., Kubota E., Hirata Y., Mizushima T., Mizoshita T., Tanaka M., Mabuchi M., Tsukamoto H., Tanida S., Kamiya T., Higashiyama S., Joh T. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells. Biochem. Biophys. Res. Commun. 2010, 402:449-454.
39. Fry J.L., Toker A. Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration. Cancer Res. 2010, 70:8187-8198.
40. Desiderio U.V., Zhu X., Evans J.P. ADAM2 interactions with mouse eggs and cell lines expressing α4/α9 (ITGA4/ITGA9) integrins: implications for integrin-based adhesion and fertilization. PLoS One 2010, 5:e13744.
41. Chalaris A., Adam N., Sina C., Rosenstiel P., Lehmann-Koch J., Schirmacher P., Hartmann D., Cichy J., Gavrilova O., Schreiber S., Jostock T., Matthews V., Häsler R., Becker C., Neurath M.F., Reiss K., Saftig P., Scheller J., Rose-John S. Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J. Exp. Med. 2010, 207:1617-1624.
42. Nariţa D., Anghel A., Seclaman E., Ilina R., Cireap N., Ursoniu S. Molecular profiling of ADAM12 gene in breast cancers. Rom. J. Morphol. Embryol. 2010, 51:669-676.
43. Tao K., Qian N., Tang Y., Ti Z., Song W., Cao D., Dou K. Increased expression of a disintegrin and metalloprotease-9 in hepatocellular carcinoma: implications for tumor progression and prognosis. Jpn. J. Clin. Oncol. 2010, 40:645-651.
44. Josson S., Anderson C.S., Sung S.Y., Johnstone P.A., Kubo H., Hsieh C.L., Arnold R., Gururajan M., Yates C., Chung L.W. Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. Prostate 2011, 71:232-240.
45. Nath D., Slocombe P.M., Webster A., Stephens P.E., Docherty A.J., Murphy G. Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1) integrin. Leading to a marked induction of fibroblast cell motility. J. Cell Sci. 2000, 113:2319-2328.
46. Zhou M., Graham R., Russell G., Croucher P.I. MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin. Biochem. Biophys. Res. Commun. 2001, 280:574-580.